{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:50:13Z","timestamp":1774659013727,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","eu-focus.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Focus"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.euf.2020.11.006","type":"journal-article","created":{"date-parts":[[2020,12,24]],"date-time":"2020-12-24T17:44:03Z","timestamp":1608831843000},"page":"980-986","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Comparison of Complication Rates with Antibiotic Prophylaxis with Cefpodoxime Versus Fluoroquinolones After Transrectal Prostate Biopsy"],"prefix":"10.1016","volume":"7","author":[{"given":"Mike","family":"Wenzel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria N.","family":"Welte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lena H.","family":"Theissen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clarissa","family":"Wittler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benedikt","family":"Hoeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Humke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix","family":"Preisser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"W\u00fcrnschimmel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derya","family":"Tilki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Graefen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederik C.","family":"Roos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre I.","family":"Karakiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Felix K.H.","family":"Chun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis A.","family":"Kluth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philipp","family":"Mandel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euf.2020.11.006_bib0005","doi-asserted-by":"crossref","DOI":"10.1038\/ng.2560","article-title":"Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array","volume":"45","author":"Eeles","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.euf.2020.11.006_bib0010","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.euf.2020.11.006_bib0015","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/annonc\/mdz051","article-title":"European cancer mortality predictions for the year 2019 with focus on breast cancer","volume":"30","author":"Malvezzi","year":"2019","journal-title":"Ann Oncol"},{"key":"10.1016\/j.euf.2020.11.006_bib0020","series-title":"EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer","author":"Mottet","year":"2020"},{"key":"10.1016\/j.euf.2020.11.006_bib0025","doi-asserted-by":"crossref","first-page":"23322","DOI":"10.18632\/oncotarget.15056","article-title":"Comparison between transrectal and transperineal prostate biopsy for detection of prostate cancer: a meta-analysis and trial sequential analysis","volume":"8","author":"Xue","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.euf.2020.11.006_bib0030","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12957-019-1573-0","article-title":"Transperineal versus transrectal prostate biopsy in the diagnosis of prostate cancer: a systematic review and meta-analysis","volume":"17","author":"Xiang","year":"2019","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.euf.2020.11.006_bib0035","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.urology.2016.12.011","article-title":"Prostate biopsy-related infection: a systematic review of risk factors, prevention strategies, and management approaches","volume":"104","author":"Roberts","year":"2017","journal-title":"Urology"},{"key":"10.1016\/j.euf.2020.11.006_bib0040","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1097\/01.ju.0000061280.23447.29","article-title":"Empirical management of urinary tract infections complicating transrectal ultrasound guided prostate biopsy","volume":"169","author":"Tal","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2020.11.006_bib0045","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.eururo.2013.05.049","article-title":"Systematic review of complications of prostate biopsy","volume":"64","author":"Loeb","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2020.11.006_bib0050","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fsurg.2020.00007","article-title":"Complication rates after TRUS guided transrectal systematic and MRI-targeted prostate biopsies in a high-risk region for antibiotic resistances","volume":"7","author":"Wenzel","year":"2020","journal-title":"Front Surg"},{"key":"10.1016\/j.euf.2020.11.006_bib0055","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1093\/jac\/dkq471","article-title":"Significant ecological impact on the progression of fluoroquinolone resistance in Escherichia coli with increased community use of moxifloxacin, levofloxacin and amoxicillin\/clavulanic acid","volume":"66","author":"Cuevas","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.euf.2020.11.006_bib0060","unstructured":"European Medicines Agency. Disabling and potentially permanentside effects lead to suspension or restrictions of quinolone and fluoroquinolone antibiotics. EMA; 2019. www.ema.europa.eu\/en\/documents\/referral\/quinolone-fluoroquinolone-article-31-referral-disabling-potentially-permanent-side-effects-lead_en.pdf."},{"key":"10.1016\/j.euf.2020.11.006_bib0065","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.euf.2018.11.009","article-title":"Update on strategies to reduce infectious complications after prostate biopsy","volume":"5","author":"Pilatz","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euf.2020.11.006_bib0070","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/JU.0000000000000814","article-title":"Antibiotic prophylaxis for the prevention of infectious complications following prostate biopsy: a systematic review and meta-analysis","volume":"204","author":"Pilatz","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2020.11.006_bib0075","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/iju.13883","article-title":"Use of fosfomycin as targeted antibiotic prophylaxis before prostate biopsy: a prospective randomized study","volume":"26","author":"Van Besien","year":"2019","journal-title":"Int J Urol"},{"key":"10.1016\/j.euf.2020.11.006_bib0080","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12894-016-0169-z","article-title":"Clinical importance of the antibiotic regimen in transrectal ultrasound-guided biopsy: quinolone versus cephalosporin","volume":"16","author":"Lee","year":"2016","journal-title":"BMC Urol"},{"key":"10.1016\/j.euf.2020.11.006_bib0085","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF02725589","article-title":"Cefpodoxime: pharmacokinetics and therapeutic uses","volume":"70","author":"Chugh","year":"2003","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.euf.2020.11.006_bib0090","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0302-2838(02)00072-6","article-title":"Bilateral fine-needle administered local anaesthetic nerve block for pain control during TRUS-guided multi-core prostate biopsy: a prospective randomised trial","volume":"41","author":"von Knobloch","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2020.11.006_bib0095","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.eururo.2016.08.004","article-title":"Complications after systematic, random, and image-guided prostate biopsy","volume":"71","author":"Borghesi","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.euf.2020.11.006_bib0100","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.juro.2014.04.098","article-title":"Nationwide population based study of infections after transrectal ultrasound guided prostate biopsy","volume":"192","author":"Lundstr\u00f6m","year":"2014","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2020.11.006_bib0105","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.juro.2009.11.043","article-title":"Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy","volume":"183","author":"Nam","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.euf.2020.11.006_bib0110","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0090-4295(02)01958-1","article-title":"Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program","volume":"60","author":"Raaijmakers","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.euf.2020.11.006_bib0115","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1080\/2090598X.2019.1592636","article-title":"Fosfomycin trometamol vs ciprofloxacin for antibiotic prophylaxis before transrectal ultrasonography-guided prostate biopsy: a meta-analysis of clinical studies","volume":"17","author":"Freitas","year":"2019","journal-title":"Arab J Urol"},{"key":"10.1016\/j.euf.2020.11.006_bib0120","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41391-018-0032-2","article-title":"Fosfomycin vs. quinolone-based antibiotic prophylaxis for transrectal ultrasound-guided biopsy of the prostate: a systematic review and meta-analysis","volume":"21","author":"Noreikaite","year":"2018","journal-title":"Prostate Cancer Prostat Dis"},{"key":"10.1016\/j.euf.2020.11.006_bib0125","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1159\/000502851","article-title":"Efficacy and safety of two fosfomycin regimens as antimicrobial prophylaxis for transrectal prostate biopsy: a randomised study","volume":"103","author":"D\u2019Elia","year":"2019","journal-title":"Urol Int"},{"key":"10.1016\/j.euf.2020.11.006_bib0130","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00345-016-1867-6","article-title":"Antimicrobial prophylaxis for transrectal ultrasound-guided prostate biopsy: fosfomycin trometamol, an attractive alternative","volume":"35","author":"Cai","year":"2017","journal-title":"World J Urol"},{"key":"10.1016\/j.euf.2020.11.006_bib0135","doi-asserted-by":"crossref","first-page":"7273","DOI":"10.1128\/AAC.01457-15","article-title":"Comparative effectiveness of single versus combination antibiotic prophylaxis for infections after transrectal prostate biopsy","volume":"59","author":"Marino","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.euf.2020.11.006_bib0140","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.urology.2014.10.047","article-title":"Reduction in hospital admissions with the addition of prophylactic intramuscular ceftriaxone before transrectal ultrasonography-guided prostate biopsies","volume":"85","author":"Luong","year":"2015","journal-title":"Urology"},{"key":"10.1016\/j.euf.2020.11.006_bib0145","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1007\/s00345-017-2043-3","article-title":"Transrectal ultrasound guided prostate biopsy in the era of increasing fluoroquinolone resistance: prophylaxis with single-dose ertapenem","volume":"35","author":"Seitz","year":"2017","journal-title":"World J Urol"}],"container-title":["European Urology Focus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456920303047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405456920303047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T06:52:39Z","timestamp":1762498359000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405456920303047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S2405456920303047"],"URL":"https:\/\/doi.org\/10.1016\/j.euf.2020.11.006","relation":{},"ISSN":["2405-4569"],"issn-type":[{"value":"2405-4569","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Complication Rates with Antibiotic Prophylaxis with Cefpodoxime Versus Fluoroquinolones After Transrectal Prostate Biopsy","name":"articletitle","label":"Article Title"},{"value":"European Urology Focus","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euf.2020.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}